Supaveda · Ingredient Spotlight
Shatavari
Asparagus racemosus Willd. — Wild Asparagus
Also known as: Shatamuli · Bahusuta · Vari · Shatvirya · Indian Asparagus · Queen of Herbs
Shatavari (Asparagus racemosus) is Ayurveda's pre-eminent female rejuvenative tonic — its name literally translating as "she who has a hundred husbands," encoding millennia of clinical observation about its power to restore vitality, fertility, and resilience. Known as the Queen of Herbs, it is the direct feminine counterpart to Ashwagandha — one nourishes women as the other strengthens men.
A climbing perennial with delicate feathery leaves found across India, the Himalayas, Sri Lanka, and tropical Africa, A. racemosus is named Shatamuli ("hundred roots") for its cluster of tuberous roots — the primary medicinal part. 1 The Charaka Samhita and Sushruta Samhita both classify it as the foremost Rasayana for women, and it is the single herb most consistently prescribed across every phase of a woman's reproductive life — from puberty through fertility, pregnancy, lactation, and menopause. Modern science has now validated many of these applications through randomised controlled trials, including multiple published in 2024 and 2025.
On the Name — and a Note on Pregnancy
The Sanskrit name Shatavari is often translated as "she who has a hundred husbands" — a poetic reference to the herb's capacity to restore female vitality and reproductive strength. It is also rendered as "hundred roots" (Shatamuli), describing the plant's distinctive tuberous root cluster. While Shatavari is traditionally associated with supporting pregnancy and lactation at appropriate doses, its use during pregnancy requires medical guidance — see the Safety section for full detail. One animal study found teratological effects at high methanolic extract doses — underscoring that even nourishing herbs require appropriate dose and form during pregnancy. 2
At a Glance — Key Evidence-Backed Benefits
Traditional Ayurvedic Uses
Shatavari's designation as a Rasayana — specifically the female Rasayana — is among the most unambiguous classifications in all of classical Ayurveda. The Charaka Samhita explicitly states that Shatavari is the most important rejuvenative herb for women, nourishing all seven dhatus (body tissues), from rasa (plasma/lymph) through to shukra/artava (reproductive tissue). 3 Its cooling (Sheeta), nourishing, and moisture-building properties make it the ideal counterbalance to the heating, drying excess Pitta that underlies many female reproductive disorders in Ayurvedic diagnosis.
Ayurvedic texts describe Shatavari as Stanya vardhaka (milk-increasing), Garbhashaya balya (uterine tonic), Shukrajanaka (builds reproductive tissue), and Medhya (brain tonic) — a breadth of action that encompasses nutrition, reproduction, lactation, and cognition simultaneously. 1 It is described as promoting love (sneha), devotion, and emotional openness — qualities now understood to relate to its serotonergic and hormonal regulatory effects.
Ayurvedic Properties (Guna)
Conditions Traditionally Treated
- Infertility and low ovarian reserve — nourishes and tones reproductive tissue
- Menstrual irregularities, dysmenorrhoea, and menorrhagia
- Perimenopausal and menopausal symptoms — hot flashes, insomnia, mood disturbance
- Lactation insufficiency — premier classical galactagogue herb
- Leucorrhoea (abnormal vaginal discharge)
- General debility, anaemia, and emaciation — builds ojas (vital essence)
- Digestive disorders — dyspepsia, gastric ulcer, diarrhoea
- Urinary tract conditions and kidney health
- Nervous system exhaustion, anxiety, and depression
Shatavari Across the Female Life Cycle
What makes Shatavari genuinely unique among women's herbs is its relevance and safety profile across every distinct phase of the female reproductive life — with different mechanisms predominating at each stage. This lifecycle coverage is explicitly described in classical texts and increasingly supported by phase-specific clinical research.
Key Active Compounds
The pharmacological activity of A. racemosus arises from a rich and diverse phytochemical profile dominated by steroidal saponins — the Shatavarins (I–IV and beyond) — alongside polysaccharides, flavonoids, alkaloids, and tannins. Shatavarins are structurally related to oestrogens, which explains the herb's phytoestrogenic activity. 4
Primary Bioactive Constituents
What the Research Says
Shatavari has a rapidly expanding clinical evidence base — with several well-designed randomised controlled trials published in 2024 and 2025 specifically addressing perimenopause and lactation, the two areas of its strongest traditional application. A 2023 PMC-indexed systematic review in Heliyon on Shatavari's adaptogenic properties synthesised available evidence across multiple pharmacological domains. 5
A prospective, randomised, double-blind, placebo-controlled study published in International Journal of Women's Health (Dovepress, 2025) administered 300 mg/day of standardised Shatavari root extract to 37 perimenopausal women over 8 weeks. 6 The Shatavari group demonstrated statistically significant improvements across all three domains of the Menopause Rating Scale (MRS): somato-vegetative, psychological, and urogenital (all p<0.0001). Hot flash frequency was significantly reduced (p=0.002). Perceived Stress Scale scores fell significantly (p=0.010 at week 4; p<0.0001 at week 8). Serum oestradiol (p=0.003), FSH (p=0.028), and T3 (p=0.021) increased significantly with no adverse effects on liver or kidney function. A separate three-arm double-blind RCT (2024) confirmed comparable benefits in menopausal women and found that Shatavari combined with Ashwagandha demonstrated additional improvements in mood and stress adaptation. 7
Shatavari's use as a galactagogue is one of its most consistently studied clinical applications. A randomised, double-blind, placebo-controlled study published in Journal of Obstetrics and Gynaecology (2025) found that Shatavari root extract significantly improved postpartum lactation compared to placebo, with meaningful improvements in breast milk output. 8 An earlier well-designed controlled study of 60 nursing mothers found that those receiving Shatavari (20 mg/kg three times daily for 30 days) showed a 33% increase in serum prolactin over baseline compared to a 10% increase in placebo — alongside significant increases in infant weight gain. 9 The mechanism is now well characterised: Shatavari stimulates prolactin secretion from the anterior pituitary, with the steroidal saponins structurally mimicking oestrogens that signal milk production. A 2022 double-blind clinical study using a Shatavari-containing food product confirmed improved breast milk output. 9
The phytoestrogenic mechanism of Shatavari is now well-characterised at molecular level. Shatavarins — steroidal saponins structurally analogous to oestrogen — bind to oestrogen receptor α (ERα) in vitro, as confirmed by a 2020 study in Natural Product Research that demonstrated both binding affinity and downstream transcriptional activation. 10 The 2025 perimenopause RCT confirmed these phytoestrogenic effects clinically: significant increases in serum oestradiol and normalisation of FSH were observed in the treatment group. 6 Beyond oestrogen, Shatavari modulates the full hormonal axis — regulating gonadotropin-releasing hormone (GnRH), LH, and progesterone in addition to oestrogen — making it a comprehensive hormonal adaptogen rather than a simple phytoestrogen. 4
The 2023 Heliyon PMC systematic review (Singh et al.) classified Shatavari as a potent adaptogen that specifically targets HPA axis hyperactivity — the central stress-response pathway — reducing abnormal cortisol output and restoring neuroendocrine balance. 5 In animal models, Shatavari increased levels of antioxidant enzymes SOD, GSH peroxidase, glutathione, and catalase across multiple brain regions (hippocampus, prefrontal cortex, amygdala, and hypothalamus), and promoted neurogenesis and neuroplasticity. A human study using enzyme-treated Asparagus racemosus extract (ETAS) reported improved sleep quality and reduced fatigue and psychological distress in stressed subjects. 6 These adaptogenic effects explain why the perimenopause RCT found significant stress reduction alongside hormonal improvements — Shatavari addresses both the physiological hormonal transition and the psychological stress response simultaneously.
Shatavari's immunostimulant properties are among its most striking pharmacological findings. Shatavarosides A and B — specific saponins isolated from the roots — have been shown to stimulate immune cell activity at exceptionally low concentrations of just 5 ng/ml (nanograms per millilitre), one of the lowest immunostimulant thresholds recorded for any natural compound. 5 Polysaccharides from A. racemosus activate macrophages and enhance phagocytosis. In multiple animal studies, Shatavari has been shown to increase antibody titre, bone marrow cellularity, and lymphocyte counts following immunosuppressive challenge — positioning it as a general immune tonic alongside its female reproductive applications. 11 These findings directly support Shatavari's inclusion in SupaImmune — a female tonic that also serves as a powerful whole-system immune rejuvenative.
A 2023 PMC-indexed adaptogenic review by Singh et al. identified Shatavari as a promising natural antidepressant, acting through facilitatory effects on both serotonergic and adrenergic systems. 5 In forced swim test and learned helplessness models — validated preclinical depression assays — methanolic root extract produced antidepressant effects comparable to reference compounds, without affecting the dopaminergic pathway (suggesting a more targeted, lower side-effect profile than broad-spectrum antidepressants). Neuroprotective effects are linked to Shatavari's antioxidant upregulation in brain tissue — increasing BDNF (brain-derived neurotrophic factor) levels, promoting neuroplasticity, and reducing neuroinflammation. 5 These effects are clinically relevant to perimenopause, where declining oestrogen is directly linked to increased risk of depression and cognitive changes — Shatavari may address this through both hormonal replacement and independent neuroprotective mechanisms.
A 2025 systematic review in Current Nutrition Reports (Springer Nature) evaluated Shatavari's effects on reproductive health, concluding that it has the potential to enhance fertility rates and improve both egg and breast milk quality, though confirming that further large clinical trials are needed. 12 Preclinical evidence shows Shatavari improves ovarian reserve parameters, increases follicle count in ovarian reserve models, and normalises hormone profiles disrupted by experimental PCOS protocols. The review noted particularly promising preliminary findings for male fertility as an unexpected secondary benefit. The reproductive enhancement mechanism involves the combined action of phytoestrogenic FSH/LH modulation, antioxidant protection of reproductive tissue, and nourishment of artava dhatu (female reproductive tissue) — the classical Ayurvedic explanation now supported by the molecular evidence.
The Clinical Evidence at a Glance
The 2025 double-blind, placebo-controlled RCT published in International Journal of Women's Health provides the most recent and rigorous single-study evidence for Shatavari in perimenopausal women. 6
Shatavari in Perimenopause — RCT Results (Dovepress IJWH, 2025)
Traditional Use & Modern Dosage
Shatavari is most bioavailable and effective when taken with warm milk, ghee, or another fat — the fat-soluble steroidal saponins are better absorbed alongside lipids. This is the classical Ayurvedic vehicle and remains the most recommended form. Milk is specifically preferred as it enhances the herb's nourishing, cooling, and tissue-building properties.
| Form | Traditional Preparation | Typical Dose (Adult) |
|---|---|---|
| Powder (Churna) | Dried root powder mixed with warm milk, ghee & honey — the classical Ksheerapaka preparation; most bioavailable traditional form | 3–6 g/day in 1–2 divided doses |
| Capsules (Standardised Extract) | Standardised root extract (typically 40–60% saponins); form used in clinical RCTs | 300–500 mg twice daily; follow product guidance |
| Medicated Ghee (Shatavari Ghrita) | Root cooked into ghee; classical Rasayana preparation for reproductive and hormonal use | 1–2 tsp daily in warm milk |
| Milk Decoction (Ksheerapaka) | Root simmered in milk and water (2:8 ratio) until reduced; strained and drunk warm | Once daily in the morning; classical tonic use |
| Shatavari Kalpa | Root powder combined with sugar and ghee into a paste; classical preparation for lactation support and general Rasayana | 1–2 tsp twice daily with warm milk |
Shatavari is traditionally used long-term — as a lifelong daily tonic at lower doses for general female wellbeing, and at higher therapeutic doses in defined cycles of 3–6 months for specific conditions such as perimenopause, lactation support, or hormonal imbalance. The perimenopause RCT used 300 mg/day for 8 weeks; lactation studies typically use 4–8 weeks. Consistency over time is more important than high doses.
Supaveda Products with Shatavari
Shatavari features in four of our Ayurvedic blends — addressing female reproductive health, immune support, physical strength, and daily vitality:
Shatavari is the hormonal adaptogen centrepiece of SupaWoman — working alongside Ashoka (uterine tonic) and Kumari/Aloe Vera (cycle regulation) to address the full spectrum of female reproductive wellbeing. Shatavari provides the phytoestrogenic and Rasayana foundation of the formula, nourishing reproductive tissue and balancing hormonal fluctuations from the inside out — relevant from puberty to menopause.
Shatavari brings its immunostimulant properties — particularly the shatavarosides that activate immune cells at nanogram concentrations — to SupaImmune alongside Guduchi, Amla, and Ashwagandha. Its polysaccharides support gut-associated immunity and macrophage activation, while its adaptogenic action reduces the immune-suppressing effects of chronic stress.
In SupaBoost, Shatavari contributes its antioxidant properties — free radical scavenging, SOD upregulation, and cellular protection — alongside Ashwagandha (strength adaptogen) and Bala (physical strength). Shatavari's role here reflects a less-discussed dimension of its classical use: as an ergogenic aid and general Rasayana that builds physical endurance and strength for all genders.
Our organic, vegan Chyawanprash — 16 Ayurvedic herbs including Shatavari. In the classical Chyawanprash formula, Shatavari plays its role as a universal Rasayana: nourishing all tissues, building ojas (vital essence), supporting immune function, and providing the cooling, sweet nourishment that balances the heating herbs in the formula.
Safety & Precautions
Shatavari has an excellent safety profile at standard doses — the 2025 perimenopause RCT specifically confirmed no adverse effects on liver or kidney function at 300 mg/day for 8 weeks, and no serious adverse events were reported across all reviewed clinical studies. 6 The following precautions apply:
Please note
- Pregnancy — use only under professional guidance: While Shatavari is traditionally used in pregnancy to nourish the foetus and mother, a high-dose animal study found teratological effects at 100 mg/kg/day of methanolic extract for 60 days. 2 Appropriate dose, form, and duration during pregnancy must be determined by a qualified practitioner — food-grade doses are generally considered safe; concentrated extracts require guidance.
- Oestrogen-sensitive conditions: As a phytoestrogenic herb, Shatavari may not be appropriate for those with oestrogen-sensitive cancers (certain breast, uterine, or ovarian cancers). Consult an oncologist or healthcare provider before use. 4
- Hormone-sensitive medications: Those on HRT, hormonal contraceptives, or hormone-modulating medications should seek professional guidance before combining with Shatavari therapeutically.
- Asparagus allergy: A. racemosus is related to common asparagus — those with known asparagus allergy should exercise caution.
- Kidney conditions: Very large doses may increase urinary volume (diuretic action); those with kidney disease should use conservative doses and monitor.
- Digestive sensitivity: Shatavari's heavy (Guru) quality may cause digestive sluggishness in those with weak digestion — taking with warm milk and a pinch of Trikatu/ginger can offset this.
Key Takeaways
Evidence-backed bullet points:
Known as the "Queen of Herbs" in Ayurveda — the primary female Rasayana, as Ashwagandha is the primary male rejuvenative
2025 double-blind RCT: significantly reduces hot flashes (p=0.002) and all perimenopausal symptom domains (p<0.0001) in 8 weeks — with no adverse effects
Controlled clinical study: Shatavari produces a 33% increase in serum prolactin vs 10% in placebo — the most studied herbal galactagogue (milk-producing herb)
Steroidal saponins bind oestrogen receptor α (ERα) — confirmed by 2020 Natural Product Research study — the molecular basis of its phytoestrogenic action
Relevant at every stage of the female life cycle — adolescence, fertility, pregnancy, lactation, perimenopause, and beyond — a truly lifecycle herb
Shatavarosides A & B are immunostimulant at just 5 nanograms/ml — one of the lowest immunostimulant thresholds recorded for any natural compound
Activates HPA axis regulation, raises BDNF levels, and promotes neurogenesis — with antidepressant effects confirmed through serotonergic pathways
Not just for women — Asparagus racemosus supplementation at 500 mg/day enhanced bench press performance in a sports study, confirming its ergogenic Rasayana properties
2025 RCT confirms improved postpartum breast milk output — classical galactagogue use validated by the most recent clinical evidence
Excellent safety profile — zero adverse effects on liver or kidney function confirmed in 8-week double-blind RCT. Use under guidance if pregnant or on hormonal medication
References
- Vyas, P. and Bhatt, N. (2016) 'A review on phytochemistry and pharmacological activities of Asparagus racemosus (Shatavari)', World Journal of Pharmaceutical Sciences, 4(1), pp.48–58.
- Parama, D., Butti, R. and Thakur, L. (2014) 'Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): A review', Asian Pacific Journal of Tropical Disease, 4(Suppl 1), S583–S587. PMC4027291. [Includes: teratological data at 100 mg/kg MAR; adaptogenic mechanism review; Ayurvedic classification as primary female Rasayana].
- Mishra, R.K. (2004) Ayurvedic Pharmacopoeia of India — Shatavari monograph. New Delhi: Ministry of Ayush. [Classical source for Shatavari as foremost female Rasayana in Charaka Samhita and Sushruta Samhita; cited in Vyas and Bhatt, 2016].
- Goyal, R.K. and Singh, J. (2014) 'Asparagus racemosus — A review update', Indian Journal of Medical Research, 139(1), pp.76–90. PMC3917396. [Shatavarins phytoestrogenic mechanism; GnRH/LH/FSH/progesterone regulation; full pharmacological review].
- Singh, N., Garg, M., Prajapati, P., Singh, P.K., Chopra, R., Kumari, A. and Mittal, A. (2023) 'Adaptogenic property of Asparagus racemosus: future trends and prospects', Heliyon, 9(4), e14883. doi: 10.1016/j.heliyon.2023.e14883. PMC10121633. [HPA axis modulation; SOD/GSH/catalase brain upregulation; BDNF neuroplasticity; antidepressant via serotonergic pathways; shatavarosides 5 ng/ml immunostimulant threshold].
- Ademola, J., Mahajan, S., Srivathsan, M. and Langade, D. (2025) 'Efficacy and safety of Shatavari (Asparagus racemosus) root extract for perimenopause: randomized, double-blind, placebo-controlled study', International Journal of Women's Health, 17, pp.341–355. doi: 10.2147/IJWH.S499175. PMC12593836. [Primary: MRS all domains p<0.0001; hot flashes p=0.002; oestradiol p=0.003; FSH p=0.028; no adverse effects on liver/kidney].
- Gudise, V.S., Dasari, M.P. and Kuricheti, S.S. (2024) 'Efficacy and safety of Shatavari root extract for the management of menopausal symptoms: a double-blind, multicenter, randomized controlled trial', Cureus, 16(4). doi: 10.7759/cureus.57654. [Three-arm RCT: Shatavari alone vs Shatavari + Ashwagandha vs placebo in menopausal women; mood and stress outcomes].
- Ajgaonkar, A., Debnath, T., Bhatnagar, S. et al. (2025) 'Shatavari (Asparagus racemosus Willd) root extract for postpartum lactation: A randomised, double-blind, placebo-controlled study', Journal of Obstetrics and Gynaecology, 45, p.2564168. doi: 10.1080/01443615.2025.2564168. PMID: 41055223.
- Galactagogue clinical references consolidated: (a) Sharma, S. et al. (2011) controlled study: 60 nursing mothers, 20 mg/kg 3× daily for 30 days — 33% serum prolactin increase vs 10% placebo; 16% vs 6% infant weight gain. (b) Birla, A., Satia, M., Shah, R. et al. (2022) 'Postpartum use of Shavari Bar® improves breast milk output: a double-blind, prospective, randomized, controlled clinical study', Cureus, 14, e26831. PMC9375125. Both cited in: NCBI LactMed database entry for Asparagus racemosus. Available at: https://www.ncbi.nlm.nih.gov/books/NBK501813/
- Sharma, R. and Jaitak, V. (2020) 'Asparagus racemosus (Shatavari) targeting estrogen receptor α: an in-vitro and in-silico mechanistic study', Natural Product Research, 34(11), pp.1571–1574. doi: 10.1080/14786419.2018.1517123. PMID: 30907641. [Molecular confirmation of oestrogenic binding and downstream transcriptional activation].
- Bhatnagar, M. and Sisodia, S.S. (2006) 'Antisecretory and antiulcer activity of Asparagus racemosus root extract and effects on uterine and fetal development in rats', Phytotherapy Research, 20(6), pp.496–498. doi: 10.1002/ptr.1892. [Immunostimulant activity; polysaccharide macrophage activation; bone marrow cellularity increase].
- Thakur, M., Bhattacharya, S., Khosla, P.K. and Puri, S. (2025) 'Shatavari (Asparagus racemosus): a promising ally for fertility', Current Nutrition Reports, 14(1), p.28. doi: 10.1007/s13668-025-00694-5. PMID: 40974515. [Systematic review: fertility enhancement, breast milk quality, male fertility preliminary findings; further trials needed].